Insider buying last 90 days
No open-market insider purchases were filed for MET in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every MET insider filing, plotted on the chart in Gekko.Open MET in Gekko
Gekko Brief
AI summaryNov 4 closeMetLife reported third-quarter 2026 results, with revenue of $20.52 billion exceeding expectations by 3.5%, while net premiums earned missed estimates and non-GAAP profit per share came in line with consensus. The CFO, John McCallion, provided a financial update video on the results, and a call to discuss the figures and outlook follows on Thursday, November 5. Separate from the quarterly report, MetLife also published research on employee benefits confidence and financial stress among workers in Bangladesh, and MetLife Korea was sanctioned over underpaid hospitalization insurance benefits in 55 cases.
MET closed at $102.89, up 2.2%, sitting above both its 50-day average of $98.04 and its 200-day average of $86.06, with the 50-day above the 200-day. The close is near its 52-week high of $103.65, after a one-month return of 5.9% and a one-year return of 29.9%. The GekkoIndex reading of 50.9 places the stock in the Neutral zone, down 4.4 over five days. Price sits 1.1% above Gekko Fair Value of $101.79.
No confirmed earnings date is currently on the calendar following this report. Across the last eight quarters, MetLife has beaten estimates five times, with an average absolute reaction of 2.2%. No insider, Congress, or unusual options activity appears in the respective 90-day and 30-day windows, and no billionaire holders are recorded, against one trailblazer holder. Seasonality over the next 20 trading days has averaged a 1.2% return across 5 years, positive in 3 of them. Analyst coverage from 12 firms shows 11 buy ratings and 1 hold, with a consensus target of $107.62.
Written by AI from the Nov 4, 2026 close and checked automatically against the figures on this page.
MetLife price vs fair value
Close $102.89200-day averageGekko Fair Value $101.79
MetLife quick facts
- Market cap
- $65.38B
- P/E ratio
- 19.2
- Forward P/E
- 11
- EPS, TTM
- $5.27
- Revenue, TTM
- $79.40B
- Profit margin
- 4.6%
- Dividend yield
- 2.29%
- Beta
- 0.77
- Volume
- 5.27M avg 3.01M
- 1-year return
- +29.9%
- Typical daily move
- ±2.1%
- Typical 20-day move
- ±4.5%
- 50-day average
- $98.04
- 200-day average
- $86.06
- Next earnings
- —
- Shares outstanding
- 635.5M
MetLife swing-trade checklist
MetLife scores 2 supportive, 2 mixed and 0 headwinds across the 4 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive2 mixed0 headwinds
- Trendsupportive
Above 50 and 200-day
Close $102.89 is above the 50-day ($98.04) and 200-day ($86.06) averages, and the 50-day is above the 200-day.
See the chart - GekkoIndexmixed
50.9, Neutral
Reading 50.9 is in the Neutral zone.
See the GekkoIndex - Fair valuemixed
1.1% above
Price is within 5% of Gekko Fair Value (1.1% above).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings riskno data
No data
No confirmed report date on the calendar.
See earnings - Seasonalitysupportive
+1.2% on average
From this point in the calendar, the next 20 trading days averaged +1.2% over 5 years, rising in 3 of them.
See seasonality
A description of current data, not a recommendation. How this page works
MetLife stock chart and price history
MetLife closed at $102.89 on Nov 4, 2026, +29.9% over the past year, inside a 52-week range of $67.33 to $103.65.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- +5.9%
- 3 months
- +2.9%
- 6 months
- +28.4%
- 1 year
- +29.9%
The full MET chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open MET in Gekko
Follow MetLife through every session
Put MET on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track MET in GekkoFree for 7 days. No credit card required.
About MetLife
MetLife sells insurance and related financial products to individuals and businesses, covering areas like life coverage, dental, disability, pet, vision and accident protection, plus prepaid legal plans. It is widely known for the sheer range of coverage types it packages together for both personal policyholders and workplace benefit programs.
Operationally, the company is split into five regional and business segments, covering the United States, Asia, Latin America, Europe/Middle East/Africa, and a separate unit for older policy blocks called MetLife Holdings. It works with employers on benefits administration, structures pension risk transfer deals, sells institutional annuities and settlement products, and builds investment offerings for capital markets clients. Customers can also access various annuity styles such as fixed, indexed and variable contracts, along with whole, term, universal and group life policies, plus reinsurance for longevity risk, credit-linked insurance, and coverage aimed at long-term care needs and executive benefit funding.
MetLife traces back to 1863 and runs its headquarters out of New York City. The stock trades on the NYSE under the ticker MET.
- Listed
- NYSE
- Sector
- Finance
- Industry
- Multi-line insurance
- Website
- metlife.com
MetLife GekkoIndex: the smart money zone
MetLife’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 50.9, in the Neutral zone, down 4.4 points over five sessions.
50.9Neutral
Down 4.4 points over five sessions.
Reading for Nov 4, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 10 | +3.5% | +10.4% | ||
| Accumulation | 195 | +0.7% | +2.5% | ||
| Neutral (current zone) | 453 | +0.2% | +0.6% | ||
| Distribution | 38 | −0.7% | +0.3% | ||
| Selling | 1 | Too few readings yet | |||
Average MET share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.0% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
See every daily GekkoIndex reading plotted over the MET price, zone by zone.Track MET in Gekko
Is MetLife stock overvalued? Gekko Fair Value
MetLife trades 1.1% above Gekko Fair Value of $101.79, so the shares are about fair value on Gekko’s estimate.
Gekko’s own estimate of what MetLife shares are worth, recalculated every trading day.
$101.79
Gekko Fair Value, Nov 4, 2026
1.1% above fair value · About fair value
At the end of Aug 2026 the price was 5.8% below the estimate.
Gekko Fair ValueShare price, month end
Gekko Fair Value on every chart, with the gap to price updating daily.Open MET in Gekko
MetLife insider and Congress trading
No open-market insider purchases were filed for MetLife, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in MET were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for MET, plotted on the chart in Gekko.Open MET in Gekko
Buybacks
MetLife has been buying back its own shares.
- Latest authorization
- $3.00B, Aug 5, 2026
- Bought back, quarter ended Jun 30, 2026
- $722.0M
- As a share of market cap
- 1.10%
- Trailing four quarters
- $2.44B
From company filings.
Hedge funds and billionaires quarter ended Jun 30
1of the funds Gekko tracks holds MET.
0added1opened0trimmed1sold out
Which funds are on each side, name by name.Unlock in Gekko
MetLife earnings: next date and track record
MetLife beat the EPS estimate in 5 of its last 8 reports, moving 2.2% on average across the report.
5 of 8reports beat the EPS estimate
±2.2%average move across the report
1 of 7reports followed by a gain
Share-price move across each report
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Nov 4, 2026 | $2.78 est $2.77 | $20.52B est $19.86B | — |
| Aug 5, 2026 | $2.43 est $2.30 | $19.08B est $19.67B | +4.0% |
| May 6, 2026 | $2.42 est $2.27 | $19.07B est $19.49B | −1.4% |
| Feb 4, 2026 | $2.58 est $2.34 | $23.81B est $27.22B | −2.1% |
| Nov 5, 2025 | $2.34 est $2.31 | $16.88B est $18.64B | −4.4% |
| Aug 6, 2025 | $2.02 est $2.15 | $17.34B est $18.53B | −1.4% |
| Apr 30, 2025 | $1.96 est $2.00 | $18.28B est $18.37B | −0.9% |
| Feb 5, 2025 | $2.09 est $2.09 | $18.38B est $19.50B | −1.1% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
MetLife stock forecast and analyst price targets
Analysts’ average 12-month price target for MetLife is $107.62, +4.6% from the last close, from 12 firms rating the stock in the last 90 days.
$107.62consensus 12-month target, +4.6% from the last close
Now $102.89Avg $107.62
Low $108High $119
Each firm’s latest rating in the last 90 days: 12 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Oct 21 | TD Cowen | $114 | +10.8% |
| Oct 15 | J.P. Morgan | $110 | +6.9% |
| Oct 12 | Bank of America Securities | $119 | +15.7% |
| Oct 12 | Piper Sandler | $110 | +6.9% |
| Oct 12 | Wells Fargo | $110 | +6.9% |
+0.6%average 20-day move after past Neutral readings
+1.2%average move over the next 20 trading days in the last 5 years
±2.1%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
MetLife seasonality: the next 20 trading days
Over the next 20 trading days from Nov 4, MetLife averaged +1.2% across the last 5 years, rising in 3 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | 0.0% | 2 of 5 |
| Next 10 trading days | +0.4% | 3 of 5 |
| Next 15 trading days | +1.0% | 3 of 5 |
| Next 20 trading days | +1.2% | 3 of 5 |
| Next 30 trading days | +0.6% | 3 of 5 |
For scale, MET’s typical 20-trading-day move in either direction is about 4.5%.
MetLife market cap and key statistics
MetLife’s market cap is $65.38B, with a P/E ratio of 19.2 and revenue of $79.40B over the last twelve months.
Valuation
- Market cap
- $65.38B
- P/E ratio
- 19.2
- Forward P/E
- 11
- EPS, TTM
- $5.27
- Gekko Fair Value
- $101.79
Trading
- Volume
- 5.27M
- Avg volume, 20 days
- 3.01M
- 52-week high
- $103.65
- 52-week low
- $67.33
- Shares outstanding
- 635.5M
Financials
- Revenue, TTM
- $79.40B
- Profit margin
- 4.6%
- Return on equity
- 13.1%
- Quarterly earnings growth, YoY
- +5.8%
Risk and income
- Beta
- 0.77
- Typical daily move
- ±2.1%
- Typical 20-day move
- ±4.5%
- Dividend yield
- 2.29%
MetLife stock news this week
Coverage of MetLife this week reads neutral: 9 positive, 12 neutral and 2 negative headlines.
- MetLife (NYSE:MET) posts better-than-expected sales in Q3 2026FinancialContent, Nov 4
- MetLife CFO John McCallion Provides Third Quarter 2026 Financial Update VideoBusiness Wire, Nov 4
- MetLife stock awaits results after US market closead-hoc-news.de, Nov 4
- MetLife, Inc. $MET Shares Newly Acquired by Mirae Asset Global Investments Co. Ltd.MarketBeat, Nov 4
- AIA Group Ltd Sells 28,963 Shares of MetLife, Inc. $METMarketBeat, Nov 4
- MetLife, Inc. (MET) Seasonal returns chart - Yahoo FinanceYahoo Finance Singapore, Nov 4
MetLife peers
MetLife’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| PGRProgressive | Neutral | 5.3% above |
| MFCManulife Financial | Neutral | 14.5% above |
| ALLAllstate | Neutral | 5.5% above |
| AFLAFLAC | Neutral | 7.0% above |
| SLFSun Life Financial | Neutral | 11.2% above |
| AIGAIG | Neutral | 0.3% above |
A peer links to its own page where one exists.
MetLife stock FAQ
What is MetLife’s market cap?
MetLife’s market cap is $65.38B at the Nov 4, 2026 close of $102.89, with 635.5M shares outstanding. The shares trade on a P/E ratio of 19.2.
What is the MetLife stock forecast?
The consensus analyst 12-month price target for MetLife is $107.62, +4.6% from the last close. Of the 12 firms that rated the stock in the last 90 days, 11 rate it a buy, 1 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is MetLife stock overvalued or undervalued?
On Gekko’s estimate MetLife is about fair value: the Nov 4, 2026 close of $102.89 is 1.1% above Gekko Fair Value of $101.79. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
What is MetLife’s 52-week high and low?
MetLife’s 52-week high is $103.65 and its 52-week low is $67.33; it closed at $102.89 on Nov 4, 2026, +29.9% over the past year.
Is MetLife stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 4 items with data read as supportive (trend and seasonality), 2 as mixed (gekkoindex and fair value). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See MetLife the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,461 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.